In Model 1, with BMI and age as additional covariables, we observed a statistically significant association between serum FABP1 levels and the risk of hyperuricemia in patients with obesity (Odds ratio [OR], 95% confidence interval [CI] = 1.023, 1.001–1.046, P = 0.048). Here, FABP1 is linked to obesity disorder.